Figure 5 | Scientific Reports

Figure 5

From: Evaluation of an 131I-labeled HER2-specific single domain antibody fragment for the radiopharmaceutical therapy of HER2-expressing cancers

Figure 5

Evaluation of the therapeutic efficacy of four doses of iso-[131I]SGMIB-VHH_1028 in SCID mice with subcutaneous BT474 xenografts. (A) Maximum tumor response waterfall plot. (B) Kaplan–Meier survival plot. The 4 treatment times are as marked with the first given at Day 0. Animal deaths due to urolithiasis related to ER pellet implantation are indicated.

Back to article page